Jonathan Richards, DPM
Podiatrist · Englewood, NJNPI 1649594193
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Kerecis Limited accounts for 67.5% of it on its own, with 31 other manufacturers making up the rest. 2025 is the largest year on record at $60,995, more than ten times the $1,864 reported in 2019. Among podiatrist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 371 payments — averaging $213.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$53K
- Stryker$13K
- Zimmer Biomet$3K
- Treace Medical Concepts, Inc.$1K
- Trilliant Surgical LLC.$905
- Royal Biologics, Inc.$810
- plus $7K from 26 others
What the payments were for
- Consulting fees$1,5252%
- Speaking & faculty fees$38,52749%
- Travel & lodging$11,16514%
- Food & beverage$23,92930%
- Education$4,0415%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 78 | $53,456 |
| Stryker(2 entities) | 138 | $13,217 |
| Zimmer Biomet | 27 | $2,689 |
| Treace Medical Concepts, Inc. | 12 | $1,479 |
| Trilliant Surgical LLC. | 3 | $905 |
| Royal Biologics, Inc. | 7 | $810 |
| Medtronic | 7 | $758 |
| Amniox Medical, Inc. | 4 | $752 |
| Novastep Inc. | 5 | $467 |
| Smith+Nephew | 12 | $458 |
| Paragon 28, Inc. | 5 | $452 |
| Medshape, Inc. | 6 | $436 |
| Integra Lifesciences Corporation | 4 | $417 |
| Amgen(2 entities) | 21 | $409 |
| Extremity Medical | 1 | $406 |
| Acera Surgical, Inc. | 2 | $304 |
| Organogenesis Inc. | 4 | $244 |
| Kowa Pharmaceuticals America, Inc. | 8 | $232 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $190 |
| Melinta Therapeutics, LLC | 4 | $175 |
| Arteriocyte Medical Systems, Inc. | 1 | $173 |
| Pfizer | 4 | $166 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $146 |
| Abbott | 2 | $142 |
| Averitas Pharma Inc. | 4 | $90 |
| Nevro Corp. | 1 | $84 |
| Orthofix Medical, Inc. | 2 | $36 |
| Boston Scientific | 1 | $26 |
| Curonix LLC | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Bioventus LLC | 1 | $15 |
| Dynasplint Systems Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$208,859
- Kerecis GraftGuide$52,215
- PROstep$2,637
- Kerecis Omega3 Marigen$1,807
- CITREFIX$1,493
- INTEGRA$1,190
- ORTHOLOC 2 LAPIFUSE$1,090
- INFINITY$1,044
- PROSTEP MICA$996
- AUGMENT INJECTABLE$990
- Arsenal Sinus Support Plate$905
- Kerecis Omega3 SurgiClose$864
- Lapiplasty System$781
- PROPHECY$740
- Fibrinet$716
- NEOX$706
- CLARIX$706
- Arsenal Ankle$647
- ALLOWRAP$615
- INTELLIS ADAPTIVESTIM$609
How this compares
$79,187 in reported general payments places this provider in the 95th percentile of 382 podiatrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 21 | $22,825 |
| Clobetasol Propionate | 14 | $496 |
| Triamcinolone Acetonide | 46 | $464 |
| CiclopiroxCiclopirox Olamine | 26 | $418 |
| Ciclopirox | 11 | $294 |
| Gabapentin | 36 | $235 |
| Fluconazole | 19 | $201 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $184 |
| Nortriptyline Hcl | 11 | $134 |
| Ibuprofen | 14 | $116 |
| Tramadol Hcl | 13 | $39 |
| Meloxicam | 17 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $458 | $22,82521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 382 podiatrist providers in New Jersey.
Other podiatrist in Englewood
- Ritchard RosenEnglewood$44K
- Jeffrey CohenEnglewood$10K
- Katherine ChenEnglewood$7K
- Gregory KaufmanEnglewood$6K
- Justin FlemingSomerset$1.2M
- Eric BaskinManahawkin$298K
- Jack BondiSewell$53K
- Matthew WohlgemuthHammonton$49K
- Michael HuchitalLyndhurst$41K
- Jeffrey GewirtzPark Ridge$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.